{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:25:09Z","timestamp":1761989109726},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Defence Research & Development Establishment"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.toxicon.2017.09.008","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T16:44:32Z","timestamp":1505407472000},"page":"58-65","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera"],"prefix":"10.1016","volume":"139","author":[{"given":"Monika","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagendra","family":"Suryanarayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urmil","family":"Tuteja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kulanthaivel","family":"Thavachelvam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.K.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2017.09.008_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1006\/bbrc.2001.5337","article-title":"Rapid purification of recombinant anthrax-protective antigen under nondenaturing conditions","volume":"286","author":"Ahuja","year":"2001","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.toxicon.2017.09.008_bib2","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1007\/s12010-009-8718-5","article-title":"Enhancement of human gamma-interferon production in recombinant E.coli using batch cultivation","volume":"160","author":"Babaeipour","year":"2010","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"4","key":"10.1016\/j.toxicon.2017.09.008_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/14787210.5.4.665","article-title":"Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism","volume":"5","author":"Bouzianas","year":"2007","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"10","key":"10.1016\/j.toxicon.2017.09.008_bib5","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00216-015-8509-5","article-title":"High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures","volume":"407","author":"Boyer","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"issue":"9","key":"10.1016\/j.toxicon.2017.09.008_bib6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/infdis\/jir543","article-title":"Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax","volume":"201","author":"Boyer","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.toxicon.2017.09.008_bib7","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/IAI.68.4.1781-1786.2000","article-title":"Role of toxin functional domains in anthrax pathogenesis","volume":"68","author":"Brossier","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2017.09.008_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrd1694","article-title":"The evolving field of biodefence: therapeutic developments and diagnostics","volume":"4","author":"Burnett","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.toxicon.2017.09.008_bib10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons","volume":"8","author":"Casadevall","year":"2002","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.toxicon.2017.09.008_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jbiotec.2006.04.038","article-title":"Single step purification of recombinant anthrax lethal factor from periplasm of Escherichia coli","volume":"126","author":"Chang","year":"2006","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.toxicon.2017.09.008_bib12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","volume":"341","author":"Dixon","year":"1999","journal-title":"Anthrax. N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.toxicon.2017.09.008_bib13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1044-0305(03)00214-9","article-title":"Protein identification: the origins of peptide mass fingerprinting","volume":"14","author":"Henzel","year":"2003","journal-title":"J.\u00a0Am. Soc. Mass Spectrom."},{"issue":"2","key":"10.1016\/j.toxicon.2017.09.008_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molimm.2015.03.255","article-title":"Review Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases","volume":"67","author":"Irani","year":"2015","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.toxicon.2017.09.008_bib15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jmb.2009.07.037","article-title":"The protective antigen component of anthrax toxin forms functional octameric complexes","volume":"392","author":"Kintzer","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.toxicon.2017.09.008_bib16","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1073\/pnas.89.21.10277","article-title":"Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin","volume":"89","author":"Klimpel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.toxicon.2017.09.008_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/IDR.S47305","article-title":"Raxibacumab: potential role in the treatment of inhalational anthrax","volume":"7","author":"Kummerfeldt","year":"2014","journal-title":"Infect. Drug Resist"},{"issue":"10","key":"10.1016\/j.toxicon.2017.09.008_bib18","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc. Natl. Acad. Sci. United States of America"},{"key":"10.1016\/j.toxicon.2017.09.008_bib19","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","article-title":"Passive protection by polyclonal antibodies against Bacillus anthracis infection in Guinea pigs","volume":"65","author":"Little","year":"1997","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.toxicon.2017.09.008_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tim.2014.02.012","article-title":"Anthrax lethal and edema toxins in anthrax pathogenesis","volume":"22","author":"Liu","year":"2014","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.toxicon.2017.09.008_bib21","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1128\/JB.183.6.2111-2116.2001","article-title":"Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin","volume":"183","author":"Mogridge","year":"2001","journal-title":"J.\u00a0Bacteriol."},{"issue":"4","key":"10.1016\/j.toxicon.2017.09.008_bib22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1172\/JCI106279","article-title":"Metabolic properties of IgG subclasses in man","volume":"49","author":"Morell","year":"1970","journal-title":"J.\u00a0Clin. Investig."},{"issue":"11","key":"10.1016\/j.toxicon.2017.09.008_bib23","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1128\/AAC.00458-13","article-title":"Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax","volume":"57","author":"Mytle","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.toxicon.2017.09.008_bib24","doi-asserted-by":"crossref","first-page":"e54933","DOI":"10.1371\/journal.pone.0054933","article-title":"Recombinant production of human interleukin 6 in Escherichia coli","volume":"8","author":"Nausch","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2017.09.008_bib25","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2017.09.008_bib26","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1128\/IAI.59.10.3472-3477.1991","article-title":"Contribution of individual toxin components to virulence of Bacillus anthracis","volume":"59","author":"Pezard","year":"1991","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.toxicon.2017.09.008_bib27","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1128\/AAC.47.7.2362-2365.2003","article-title":"Vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin","volume":"47","author":"Price","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.toxicon.2017.09.008_bib28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrmicro977","article-title":"Antitoxins: novel strategies to target agents of bioterrorism","volume":"2","author":"Rainey","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.toxicon.2017.09.008_bib29","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.toxicon.2017.09.008_bib30","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Scobie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.toxicon.2017.09.008_bib31","first-page":"163","article-title":"Isolation, solubilization, refolding, and chromatographic purification of human growth hormone from inclusion bodies of Escherichia coli cells: a case study","volume":"308","author":"Singh","year":"2005","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.toxicon.2017.09.008_bib32","doi-asserted-by":"crossref","first-page":"11099","DOI":"10.1016\/S0021-9258(18)60433-8","article-title":"Internalization and processing of Bacillus anthracis lethal toxin by toxin-sensitive and resistant cells","volume":"264","author":"Singh","year":"1989","journal-title":"J.\u00a0Biol. Chem."},{"issue":"10","key":"10.1016\/j.toxicon.2017.09.008_bib33","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1172\/JCI105917","article-title":"Catabolism of human \u03b3G-immunoglobulins of different heavy chain subclasses: I. Catabolism of \u03b3G-myeloma proteins in man","volume":"47","author":"Spiegelberg","year":"1968","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.toxicon.2017.09.008_bib34","article-title":"Soluble expression and characterization of biologically active Bacillus anthracis protective antigen in Escherichia coli","volume":"4732791","author":"Suryanarayana","year":"2016","journal-title":"Mol. Biol. Int."},{"issue":"19","key":"10.1016\/j.toxicon.2017.09.008_bib36","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.1007\/s00253-016-7684-4","article-title":"Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model","volume":"100","author":"Suryanarayana","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"4","key":"10.1016\/j.toxicon.2017.09.008_bib37","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/IAI.67.4.1860-1865.1999","article-title":"Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin","volume":"67","author":"Varughese","year":"1999","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.toxicon.2017.09.008_bib38","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1042\/bj3520739","article-title":"Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor","volume":"352","author":"Vitale","year":"2000","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.toxicon.2017.09.008_bib39","article-title":"Bacillus anthracis secretome time course under host-simulated conditions and identification of immunogenic proteins","volume":"5","author":"Walz","year":"2007","journal-title":"Proteome Sci."},{"issue":"10","key":"10.1016\/j.toxicon.2017.09.008_bib40","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1128\/AAC.00972-16","article-title":"Efficacy projection of obiltoxaximab for treatment of inhalational anthrax across a range of disease severity","volume":"60","author":"Yamamoto","year":"2016","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010117302817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010117302817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T17:36:13Z","timestamp":1659461773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010117302817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":37,"alternative-id":["S0041010117302817"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2017.09.008","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2017.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}